Impact of Neoadjuvant Chemotherapy on Postoperative Morbidity in Locally Advanced Cervical Carcinoma.
Identifieur interne : 009437 ( Main/Exploration ); précédent : 009436; suivant : 009438Impact of Neoadjuvant Chemotherapy on Postoperative Morbidity in Locally Advanced Cervical Carcinoma.
Auteurs : Tae Sung Lee ; Mi Suk Kim ; Suk Bong Koh ; Youn Seok ChoiSource :
- Cancer research and treatment : official journal of Korean Cancer Association [ 1598-2998 ] ; 2002.
Abstract
The purpose of this study was to test the hypothesis that neoadjuvant chemotherapy (NACT) does not increase morbidity in patients undergoing radical hysterectomy with lymphadenectomy for locally advanced cervical cancer. MATERIALS AND METGODS: A retrospective study was undertaken of 140 patients with locally advanced cervical cancer (FIGO stage Ia to IIb) who underwent radical hysterectomy with lymphadenectomy by the same surgeon at the same hospital. Among the 140 patients, 39 received NACT followed by radical hysterectomy with pelvic lymphadenectomy (NACT group). This group received three cycles consisting of cisplatin 100 mg/m2/day on day 1 and 5-fluorouracil 1000 mg/m2/day from day 1 to 5. The NACT group was compared, in terms of intraoperative morbidity and postoperative morbidity, with the other 101 patients who underwent radical hysterectomy with lymphadenectomy but without chemotherapy (surgery-only group).
DOI: 10.4143/crt.2002.34.3.186
PubMed: 26680861
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 004571
- to stream PubMed, to step Curation: 004571
- to stream PubMed, to step Checkpoint: 004571
- to stream Ncbi, to step Merge: 007C41
- to stream Ncbi, to step Curation: 007C41
- to stream Ncbi, to step Checkpoint: 007C41
- to stream Main, to step Merge: 009796
- to stream Main, to step Curation: 009437
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Impact of Neoadjuvant Chemotherapy on Postoperative Morbidity in Locally Advanced Cervical Carcinoma.</title>
<author><name sortKey="Lee, Tae Sung" sort="Lee, Tae Sung" uniqKey="Lee T" first="Tae Sung" last="Lee">Tae Sung Lee</name>
</author>
<author><name sortKey="Kim, Mi Suk" sort="Kim, Mi Suk" uniqKey="Kim M" first="Mi Suk" last="Kim">Mi Suk Kim</name>
</author>
<author><name sortKey="Koh, Suk Bong" sort="Koh, Suk Bong" uniqKey="Koh S" first="Suk Bong" last="Koh">Suk Bong Koh</name>
</author>
<author><name sortKey="Choi, Youn Seok" sort="Choi, Youn Seok" uniqKey="Choi Y" first="Youn Seok" last="Choi">Youn Seok Choi</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2002">2002</date>
<idno type="RBID">pubmed:26680861</idno>
<idno type="pmid">26680861</idno>
<idno type="doi">10.4143/crt.2002.34.3.186</idno>
<idno type="wicri:Area/PubMed/Corpus">004571</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004571</idno>
<idno type="wicri:Area/PubMed/Curation">004571</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004571</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004571</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004571</idno>
<idno type="wicri:Area/Ncbi/Merge">007C41</idno>
<idno type="wicri:Area/Ncbi/Curation">007C41</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">007C41</idno>
<idno type="wicri:doubleKey">1598-2998:2002:Lee T:impact:of:neoadjuvant</idno>
<idno type="wicri:Area/Main/Merge">009796</idno>
<idno type="wicri:Area/Main/Curation">009437</idno>
<idno type="wicri:Area/Main/Exploration">009437</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Impact of Neoadjuvant Chemotherapy on Postoperative Morbidity in Locally Advanced Cervical Carcinoma.</title>
<author><name sortKey="Lee, Tae Sung" sort="Lee, Tae Sung" uniqKey="Lee T" first="Tae Sung" last="Lee">Tae Sung Lee</name>
</author>
<author><name sortKey="Kim, Mi Suk" sort="Kim, Mi Suk" uniqKey="Kim M" first="Mi Suk" last="Kim">Mi Suk Kim</name>
</author>
<author><name sortKey="Koh, Suk Bong" sort="Koh, Suk Bong" uniqKey="Koh S" first="Suk Bong" last="Koh">Suk Bong Koh</name>
</author>
<author><name sortKey="Choi, Youn Seok" sort="Choi, Youn Seok" uniqKey="Choi Y" first="Youn Seok" last="Choi">Youn Seok Choi</name>
</author>
</analytic>
<series><title level="j">Cancer research and treatment : official journal of Korean Cancer Association</title>
<idno type="ISSN">1598-2998</idno>
<imprint><date when="2002" type="published">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The purpose of this study was to test the hypothesis that neoadjuvant chemotherapy (NACT) does not increase morbidity in patients undergoing radical hysterectomy with lymphadenectomy for locally advanced cervical cancer. MATERIALS AND METGODS: A retrospective study was undertaken of 140 patients with locally advanced cervical cancer (FIGO stage Ia to IIb) who underwent radical hysterectomy with lymphadenectomy by the same surgeon at the same hospital. Among the 140 patients, 39 received NACT followed by radical hysterectomy with pelvic lymphadenectomy (NACT group). This group received three cycles consisting of cisplatin 100 mg/m2/day on day 1 and 5-fluorouracil 1000 mg/m2/day from day 1 to 5. The NACT group was compared, in terms of intraoperative morbidity and postoperative morbidity, with the other 101 patients who underwent radical hysterectomy with lymphadenectomy but without chemotherapy (surgery-only group).</div>
</front>
</TEI>
<affiliations><list></list>
<tree><noCountry><name sortKey="Choi, Youn Seok" sort="Choi, Youn Seok" uniqKey="Choi Y" first="Youn Seok" last="Choi">Youn Seok Choi</name>
<name sortKey="Kim, Mi Suk" sort="Kim, Mi Suk" uniqKey="Kim M" first="Mi Suk" last="Kim">Mi Suk Kim</name>
<name sortKey="Koh, Suk Bong" sort="Koh, Suk Bong" uniqKey="Koh S" first="Suk Bong" last="Koh">Suk Bong Koh</name>
<name sortKey="Lee, Tae Sung" sort="Lee, Tae Sung" uniqKey="Lee T" first="Tae Sung" last="Lee">Tae Sung Lee</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 009437 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 009437 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:26680861 |texte= Impact of Neoadjuvant Chemotherapy on Postoperative Morbidity in Locally Advanced Cervical Carcinoma. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26680861" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |